The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact
Open Access
- 5 August 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 172 (5) , 517-524
- https://doi.org/10.1093/aje/kwq211
Abstract
Recent emphasis on translational research (TR) is highlighting the role of epidemiology in translating scientific discoveries into population health impact. The authors present applications of epidemiology in TR through 4 phases designated T1–T4, illustrated by examples from human genomics. In T1, epidemiology explores the role of a basic scientific discovery (e.g., a disease risk factor or biomarker) in developing a “candidate application” for use in practice (e.g., a test used to guide interventions). In T2, epidemiology can help to evaluate the efficacy of a candidate application by using observational studies and randomized controlled trials. In T3, epidemiology can help to assess facilitators and barriers for uptake and implementation of candidate applications in practice. In T4, epidemiology can help to assess the impact of using candidate applications on population health outcomes. Epidemiology also has a leading role in knowledge synthesis, especially using quantitative methods (e.g., meta-analysis). To explore the emergence of TR in epidemiology, the authors compared articles published in selected issues of the Journal in 1999 and 2009. The proportion of articles identified as translational doubled from 16% (11/69) in 1999 to 33% (22/66) in 2009 (P = 0.02). Epidemiology is increasingly recognized as an important component of TR. By quantifying and integrating knowledge across disciplines, epidemiology provides crucial methods and tools for TR.Keywords
This publication has 49 references indexed in Scilit:
- An agenda for personalized medicineNature, 2009
- Comparative effectiveness research and genomic medicine: An evolving partnership for 21st century medicineGenetics in Medicine, 2009
- Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a MutationJAMA, 2009
- A translational framework for public health researchBMC Public Health, 2009
- Genome-based prediction of common diseases: methodological considerations for future researchGenome Medicine, 2009
- Epidemiology: Key to Translational, Team, and Transdisciplinary ScienceAnnals of Epidemiology, 2008
- Practice-Based Research—“Blue Highways” on the NIH RoadmapJAMA, 2007
- Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Recommendation StatementAnnals of Internal Medicine, 2005
- Central Challenges Facing the National Clinical Research EnterpriseJAMA, 2003
- Modeling the Impact of Subclinical Measles Transmission in Vaccinated Populations with Waning ImmunityAmerican Journal of Epidemiology, 1999